Skip Nav Destination
Close Modal
Update search
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Date
Availability
Search All AAP Sites
Can't find what you're looking for? Search for content across all of AAP's sites.
1-20 of 66
RSV
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
News
Study: RSV hospitalizations for youngest babies cut in half after immunizations become available
FreePublished: May 08, 2025
Abstract
This season was the first in which infants could be protected by a maternal RSV vaccine given during pregnancy or a monoclonal antibody given in their first months of life.
News
Published: April 18, 2025
TOPICS:
Infectious Diseases,
Influenza,
RSV,
COVID-19
Abstract
The CDC still recommends a flu shot this season for everyone 6 months and older.
News
Published: April 16, 2025
Abstract
ACIP also discussed extending use of a meningococcal vaccine to infants and toddlers and a new monoclonal antibody to protect infants from RSV.
News
Published: March 21, 2025
Abstract
The agenda includes meningococcal, chikungunya, influenza, COVID-19, RSV, HPV, mpox and Lyme disease vaccines.
News
Published: February 20, 2025
Abstract
Leaders at the AAP are calling on federal officials to reschedule a vaccine advisory committee meeting hosted by the Centers for Disease Control and Prevention after the meeting was abruptly postponed.
News
Published: December 14, 2024
Abstract
Members of a Food and Drug Administration committee said more information is needed before reaching any conclusions about an RSV vaccine clinical trial paused by Moderna last summer.
News
Published: November 21, 2024
Abstract
The schedules incorporate policies approved over the past year and tweaks to improve clarity and readability. They have been endorsed by the AAP.
News
Published: November 15, 2024
Abstract
Surveys of 400 health care professionals released by the CDC found most pediatricians and OB/GYNs had offered immunizations for RSV to their patients and expressed confidence in the safety and effectiveness of the products.
News
Published: October 31, 2024
TOPICS:
Fetus/Newborn Infant,
Hematology/Oncology,
Infectious Diseases,
Ophthalmology,
Pharmacology,
RSV,
Vaccine/Immunization
Abstract
Supply chain issues, manufacturing difficulties and increased demand have contributed to supply issues with a variety of drugs, immunizations and medical devices.
News
Published: October 23, 2024
Abstract
The CDC advisers also discussed a new RSV immunization on the horizon for infants.
News
Health officials express concern about low vaccination rates as respiratory virus season begins
FreePublished: September 26, 2024
Abstract
Just 54% of children and adolescents were vaccinated against flu last season while about 14% got an updated COVID-19 vaccine.
News
Published: September 16, 2024
TOPICS:
Infectious Diseases,
Maternal and Fetal Medicine,
Neonatology,
Obstetrics,
RSV,
Vaccine/Immunization
Abstract
The FDA has approved a new filling line to expand production following supply shortages that plagued last year’s rollout.
News
Published: August 08, 2024
TOPICS:
Fetus/Newborn Infant,
Infectious Diseases,
Maternal and Fetal Medicine,
RSV,
Vaccine/Immunization
Abstract
Nirsevimab was 91%-98% effective at preventing RSV hospitalizations.
News
Published: July 01, 2024
Abstract
Feedback from pediatricians is crucial when the AAP advocates for new payment code values, as in new rates for administration and counseling of nirsevimab.
News
Published: July 01, 2024
TOPICS:
Infectious Diseases,
Respiratory Tract,
RSV,
Vaccine/Immunization,
COVID-19,
Diversity, equity and inclusion
Abstract
The COVID-19 pandemic emphasized how inequities based on race and socioeconomic status impact the risk of infection and infection-related outcomes in children.
News
Published: June 28, 2024
Abstract
A federal vaccine committee called nirsevimab’s effectiveness “outstanding.”
News
Published: May 08, 2024
Abstract
Providers will have until May 17 to submit their forecasted needs for RSV immunization nirsevimab next season.
News
Published: April 12, 2024
Abstract
The new list price per dose is $519.75, which is a 5% increase.
News
Published: March 07, 2024
Abstract
RSV is the leading cause of hospitalization in infants.
News
Published: March 01, 2024
TOPICS:
Influenza,
RSV,
Vaccine/Immunization,
COVID-19
Abstract
The Centers for Disease Control and Prevention has updated guidance for those infected with respiratory viruses, including COVID-19, flu and RSV.
1
